162 related articles for article (PubMed ID: 37036017)
21. Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis.
Mi J; Wang R; Han X; Ma R; Li H
Medicine (Baltimore); 2023 Dec; 102(48):e36228. PubMed ID: 38050202
[TBL] [Abstract][Full Text] [Related]
22. RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.
Yao J; Zang W; Ge Y; Weygant N; Yu P; Li L; Rao G; Jiang Z; Yan R; He L; Yu Y; Jin M; Cheng G; An G
Can J Gastroenterol Hepatol; 2018; 2018():4248971. PubMed ID: 29707525
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review.
Fan G; Zhang K; Yang X; Ding J; Wang Z; Li J
PLoS One; 2017; 12(2):e0171991. PubMed ID: 28187169
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis.
Callesen LB; Hamfjord J; Boysen AK; Pallisgaard N; Guren TK; Kure EH; Spindler KG
Br J Cancer; 2022 Aug; 127(3):500-513. PubMed ID: 35440666
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Significance of Molecular Analysis of Peritoneal Fluid for Patients with Gastric Cancer: A Meta-Analysis.
Deng K; Zhu H; Chen M; Wu J; Hu R; Tang C
PLoS One; 2016; 11(3):e0151608. PubMed ID: 26986965
[TBL] [Abstract][Full Text] [Related]
26. Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives.
Grizzi G; Salati M; Bonomi M; Ratti M; Holladay L; De Grandis MC; Spada D; Baiocchi GL; Ghidini M
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298371
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis.
Taliento C; Morciano G; Nero C; Froyman W; Vizzielli G; Pavone M; Salvioli S; Tormen M; Fiorica F; Scutiero G; Scambia G; Giorgi C; Greco P; Pinton P
Int J Gynecol Cancer; 2024 Jun; 34(6):906-918. PubMed ID: 38658022
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumour DNA as Biomarker for Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
Wullaert L; van Rees JM; Martens JWM; Verheul HMW; Grünhagen DJ; Wilting SM; Verhoef C
Cells; 2023 Oct; 12(21):. PubMed ID: 37947598
[TBL] [Abstract][Full Text] [Related]
29. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Chidharla A; Rapoport E; Agarwal K; Madala S; Linares B; Sun W; Chakrabarti S; Kasi A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373376
[TBL] [Abstract][Full Text] [Related]
30. Circulation tumour DNA in predicting recurrence and prognosis in operable colorectal cancer patients: A meta-analysis.
Mi J; Han X; Wang R; Ma R; Zhao D
Eur J Clin Invest; 2022 Dec; 52(12):e13842. PubMed ID: 35856399
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis.
Papakonstantinou A; Gonzalez NS; Pimentel I; Suñol A; Zamora E; Ortiz C; Espinosa-Bravo M; Peg V; Vivancos A; Saura C; Villacampa G; Oliveira M
Cancer Treat Rev; 2022 Mar; 104():102362. PubMed ID: 35219090
[TBL] [Abstract][Full Text] [Related]
32. Using Circulating Tumor DNA as a Novel Biomarker to Screen and Diagnose Colorectal Cancer: A Meta-Analysis.
Min L; Chen J; Yu M; Liu D
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675337
[TBL] [Abstract][Full Text] [Related]
33. Circulating tumour DNA and melanoma survival: A systematic literature review and meta-analysis.
Gandini S; Zanna I; De Angelis SP; Cocorocchio E; Queirolo P; Lee JH; Carlino MS; Mazzarella L; Achutti Duso B; Palli D; Raimondi S; Caini S
Crit Rev Oncol Hematol; 2021 Jan; 157():103187. PubMed ID: 33276181
[TBL] [Abstract][Full Text] [Related]
34. The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis.
Lu Y; Li L
Technol Cancer Res Treat; 2021; 20():15330338211043784. PubMed ID: 34817271
[No Abstract] [Full Text] [Related]
35. Clinical significance of circulating tumor DNA in localized non-small cell lung cancer: a systematic review and meta-analysis.
Guo RQ; Peng JZ; Sun J; Li YM
Clin Exp Med; 2023 Sep; 23(5):1621-1631. PubMed ID: 36315311
[TBL] [Abstract][Full Text] [Related]
36. Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA.
Lyskjær I; Kara N; De Noon S; Davies C; Rocha AM; Strobl AC; Usher I; Gerrand C; Strauss SJ; Schrimpf D; von Deimling A; Beck S; Flanagan AM
Eur J Cancer; 2022 Jun; 168():1-11. PubMed ID: 35421838
[TBL] [Abstract][Full Text] [Related]
37. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study.
Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P; Roberts TL
Lung Cancer; 2019 Aug; 134():187-193. PubMed ID: 31319980
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
Fan G; Zhang K; Ding J; Li J
Oncotarget; 2017 May; 8(20):33922-33932. PubMed ID: 28430611
[TBL] [Abstract][Full Text] [Related]
39. Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.
van Velzen MJM; Creemers A; van den Ende T; Schokker S; Krausz S; Reinten RJ; Dijk F; van Noesel CJM; Halfwerk H; Meijer SL; Mearadji B; Derks S; Bijlsma MF; van Laarhoven HWM
Gastric Cancer; 2022 Sep; 25(5):906-915. PubMed ID: 35763187
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
